Robert Auciaux

Board Director

Director

US·SEC (Form 4)

Usana Health Sciences Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€51k

Latest filing published 11 May 2022 for Usana Health Sciences INC. Read the official filing

Filing timeline

BuySale

Robert Auciaux

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Robert Auciaux: trading record in brief

Robert Auciaux (board member) discloses dealings in Usana Health Sciences Inc to SEC (Form 4). In total, 6 filings cover trades dated from 17 June 2021 to 9 May 2022.

No open-market purchase appears, only 1 sale worth €51k. Besides market trades, the filings include 5 option exercises.

The newest entry dates from 11 May 2022: an option exercise, in Usana Health Sciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.